208 related articles for article (PubMed ID: 24403505)
81. [Progress of the mechanism for chemotherapeutic drugs induced neurotoxicity and its clinical treatment research].
Zhang JZ; Zheng WH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):286-8. PubMed ID: 22574611
[No Abstract] [Full Text] [Related]
82. Inorganic Nano-Targeted Drugs Delivery System and Its Application of Platinum-Based Anticancer Drugs.
Chen J; Gao C; Zhang Y; Wang T; Qian Y; Yang B; Dong P; Zhang Y
J Nanosci Nanotechnol; 2017 Jan; 17(1):1-17. PubMed ID: 29616785
[TBL] [Abstract][Full Text] [Related]
83. [Central nervous system neurotoxicity of anticancer chemotherapy].
Yoshida M
Nihon Rinsho; 2015 Feb; 73 Suppl 2():475-9. PubMed ID: 25831806
[No Abstract] [Full Text] [Related]
84. Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton.
Malacrida A; Meregalli C; Rodriguez-Menendez V; Nicolini G
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075828
[TBL] [Abstract][Full Text] [Related]
85. Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.
Anderson JT; Huang KM; Lustberg MB; Sparreboom A; Hu S
Rev Physiol Biochem Pharmacol; 2022; 183():177-215. PubMed ID: 32761456
[TBL] [Abstract][Full Text] [Related]
86. Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.
Cavaletti G; Alberti P; Marmiroli P
Lancet Oncol; 2011 Nov; 12(12):1151-61. PubMed ID: 21719347
[TBL] [Abstract][Full Text] [Related]
87. Minimizing Risk of Cancer Therapeutics.
Clark M
Phys Med Rehabil Clin N Am; 2018 Nov; 29(4):701-719. PubMed ID: 30293625
[TBL] [Abstract][Full Text] [Related]
88. Chemotherapy-induced peripheral neurotoxicity - outcome measures: the issue.
Alberti P
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):241-243. PubMed ID: 27819147
[No Abstract] [Full Text] [Related]
89. Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Expert Opin Pharmacother; 2018 Feb; 19(2):113-121. PubMed ID: 29219629
[TBL] [Abstract][Full Text] [Related]
90. Neurologic Complications of Systemic Anticancer Therapy.
Ly KI; Arrillaga-Romany IC
Neurol Clin; 2018 Aug; 36(3):627-651. PubMed ID: 30072074
[TBL] [Abstract][Full Text] [Related]
91. Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity.
Chiorazzi A; Semperboni S; Marmiroli P
Toxics; 2015 Aug; 3(3):304-321. PubMed ID: 29051466
[TBL] [Abstract][Full Text] [Related]
92. Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future research.
Alberti P; Lehmann HC
Exp Neurol; 2021 Mar; 337():113555. PubMed ID: 33340795
[No Abstract] [Full Text] [Related]
93. The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.
Hucke A; Ciarimboli G
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S157-72. PubMed ID: 27385173
[TBL] [Abstract][Full Text] [Related]
94. Neurotoxicity of biologically targeted agents in pediatric cancer trials.
Wells EM; Nageswara Rao AA; Scafidi J; Packer RJ
Pediatr Neurol; 2012 Apr; 46(4):212-21. PubMed ID: 22490765
[TBL] [Abstract][Full Text] [Related]
95. PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth.
Jiang ZG; Fuller SA; Ghanbari HA
Oxid Med Cell Longev; 2016; 2016():9392404. PubMed ID: 26640619
[TBL] [Abstract][Full Text] [Related]
96. Neurologic complications of chemotherapy for children with cancer.
Reddy AT; Witek K
Curr Neurol Neurosci Rep; 2003 Mar; 3(2):137-42. PubMed ID: 12583842
[TBL] [Abstract][Full Text] [Related]
97. Mapping Drug-Induced Neuropathy through In-Situ Motor Protein Tracking and Machine Learning.
Yi Z; Gao H; Ji X; Yeo XY; Chong SY; Mao Y; Luo B; Shen C; Han S; Wang JW; Jung S; Shi P; Ren H; Liu X
J Am Chem Soc; 2021 Sep; 143(36):14907-14915. PubMed ID: 34469145
[TBL] [Abstract][Full Text] [Related]
98. Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development.
Balmer NV; Leist M
Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):59-68. PubMed ID: 24476462
[TBL] [Abstract][Full Text] [Related]
99. The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics.
Prša P; Karademir B; Biçim G; Mahmoud H; Dahan I; Yalçın AS; Mahajna J; Milisav I
Biochem Pharmacol; 2020 Mar; 173():113551. PubMed ID: 31185225
[TBL] [Abstract][Full Text] [Related]
100. Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.
Mann A; Semenenko I; Meir M; Eyal S
AAPS J; 2015 Jul; 17(4):788-801. PubMed ID: 25823669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
